Eli Lilly CDR Logo

Eli Lilly CDR (LLY)

NEO

Currency in CAD
45.04
+0.39 (+0.87%)

Closed

Aug 21, 2026

Day's Range

44.06
45.33

52 wk Range

25.42
46.18

Overview - LLY - Eli Lilly CDR

Key Statistics

Valuation

Enterprise Value

92.88B

P/E (Trailing)

‪58.49‬

PEG Ratio

‪2.23‬

Price / Sales (TTM)

‪26.10‬

Price / Book

‪1.23‬

EV / EBITDA

‪2.35‬

Profitability

Gross Margin

‪85.77%‬

Profit Margin

‪30.98%‬

Operating Margin

‪48.29%‬

Return on Assets

‪17.60%‬

Return on Equity

‪96.47%‬

Ownership

Shares Outstanding

891.50M

Float

893.12M

Short % of Shares Outstanding

‪0.00%‬

Price stats

Beta

‪0.36‬

50-Day Avg

‪36.30‬

200-Day Avg

‪30.34‬

Dividends

Payout Ratio

‪27.52%‬

Frequency

Quarterly

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 19, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - LLY - Eli Lilly CDR

Peers - LLY - Eli Lilly CDR

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on NEO.

Profile Summary - LLY - Eli Lilly CDR

About

Eli Lilly CDR is a Canadian Depositary Receipt (CAD Hedged) providing Canadian investors exposure to Eli Lilly and Company, a leading global pharmaceutical firm founded in 1876 and headquartered in Indianapolis, Indiana. Eli Lilly engages in the discovery, development, manufacture, and sale of innovative prescription…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees47K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.